Identification of p53 as a sequence-specific DNA-binding protein
- PMID: 2047879
- DOI: 10.1126/science.2047879
Identification of p53 as a sequence-specific DNA-binding protein
Abstract
The tumor-suppressor gene p53 is altered by missense mutation in numerous human malignancies. However, the biochemical properties of p53 and the effect of mutation on these properties are unclear. A human DNA sequence was identified that binds specifically to wild-type human p53 protein in vitro. As few as 33 base pairs were sufficient to confer specific binding. Certain guanines within this 33-base pair region were critical, as methylation of these guanines or their substitution with thymine-abrogated binding. Human p53 proteins containing either of two missense mutations commonly found in human tumors were unable to bind significantly to this sequence. These data suggest that a function of p53 may be mediated by its ability to bind to specific DNA sequences in the human genome, and that this activity is altered by mutations that occur in human tumors.
Similar articles
-
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.Cell. 1991 Jun 14;65(6):1083-91. doi: 10.1016/0092-8674(91)90560-l. Cell. 1991. PMID: 1646078
-
YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.Mol Cell Biol. 1996 Oct;16(10):5933-45. doi: 10.1128/MCB.16.10.5933. Mol Cell Biol. 1996. PMID: 8816507 Free PMC article.
-
A transcriptionally active DNA-binding site for human p53 protein complexes.Mol Cell Biol. 1992 Jun;12(6):2866-71. doi: 10.1128/mcb.12.6.2866-2871.1992. Mol Cell Biol. 1992. PMID: 1588974 Free PMC article.
-
Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.Oncogene. 1994 Jul;9(7):1899-906. Oncogene. 1994. PMID: 8208536
-
Interaction of tumor suppressor p53 with DNA and proteins.Curr Pharm Biotechnol. 2010 Jan;11(1):122-7. doi: 10.2174/138920110790725366. Curr Pharm Biotechnol. 2010. PMID: 20214611 Review.
Cited by
-
Biological clues to potent DNA-damaging activities in food and flavoring.Food Chem Toxicol. 2013 May;55:557-67. doi: 10.1016/j.fct.2013.01.058. Epub 2013 Feb 8. Food Chem Toxicol. 2013. PMID: 23402862 Free PMC article.
-
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.Mol Cell Biol. 1992 Nov;12(11):5041-9. doi: 10.1128/mcb.12.11.5041-5049.1992. Mol Cell Biol. 1992. PMID: 1406679 Free PMC article.
-
Wild-type p53 binds to the TATA-binding protein and represses transcription.Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12028-32. doi: 10.1073/pnas.89.24.12028. Proc Natl Acad Sci U S A. 1992. PMID: 1465435 Free PMC article.
-
Ubiquitin-immunoreactive degradation products of cytokeratin 8/18 correlate with aggressive breast cancer.Cancer Sci. 2003 Oct;94(10):864-70. doi: 10.1111/j.1349-7006.2003.tb01368.x. Cancer Sci. 2003. PMID: 14556659 Free PMC article.
-
Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.Cell Cycle. 2010 Sep 1;9(17):3428-37. doi: 10.4161/cc.9.17.12998. Epub 2010 Sep 13. Cell Cycle. 2010. PMID: 20818159 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous